(6-(phenoxy)-pyrido`3,4-d! pyrimidin2-yl)-amine derivatives as p38 kinase inhibitors for the treatment of inflammatoryy conditions such as rheumatois artritis

Details for Australian Patent Application No. 2004229163 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Goldstein, David Michael; Dewdney, Nolan James

Agent Davies Collison Cave

Pub. Number AU-A-2004229163

PCT Pub. Number WO2004/091625

Priority 60/463,229 16.04.03 US

Filing date 13 April 2004

Wipo publication date 28 October 2004

International Classifications

A61K 031/519 - ortho- or peri-condensed with heterocyclic rings

C07D 471/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61P 019/02 Drugs for skeletal disorders

Event Publications

3 November 2005 PCT application entered the National Phase

  PCT publication WO2004/091625 Priority application(s): WO2004/091625

3 January 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004229165-Multi-vitamin and mineral supplement for pregnant women

2004229159-Medical active agent patch optically less visible on skin